BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26075256)

  • 1. Well-designed bone-seeking radiolabeled compounds for diagnosis and therapy of bone metastases.
    Ogawa K; Ishizaki A
    Biomed Res Int; 2015; 2015():676053. PubMed ID: 26075256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases.
    Lam MG; de Klerk JM; van Rijk PP; Zonnenberg BA
    Anticancer Agents Med Chem; 2007 Jul; 7(4):381-97. PubMed ID: 17630915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiometabolic treatment of bone-metastasizing cancer: from 186rhenium to 223radium.
    Rubini G; Nicoletti A; Rubini D; Asabella AN
    Cancer Biother Radiopharm; 2014 Feb; 29(1):1-11. PubMed ID: 24180669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted radio-nuclide therapy of skeletal metastases.
    Sartor O; Hoskin P; Bruland OS
    Cancer Treat Rev; 2013 Feb; 39(1):18-26. PubMed ID: 22534284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiopharmaceuticals for metastatic bone pain palliation: available options in the clinical domain and their comparisons.
    Das T; Banerjee S
    Clin Exp Metastasis; 2017 Jan; 34(1):1-10. PubMed ID: 27988895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radionuclide therapy with bone seeking radionuclides in palliation of painful bone metastases.
    Maini CL; Sciuto R; Romano L; Bergomi S
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):71-4. PubMed ID: 16767910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiopharmaceuticals for bone lesions. Imaging and therapy in clinical practice.
    Pauwels EK; Stokkel MP
    Q J Nucl Med; 2001 Mar; 45(1):18-26. PubMed ID: 11456371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone-targeting radiopharmaceuticals including radium-223.
    Brady D; Parker CC; O'Sullivan JM
    Cancer J; 2013; 19(1):71-8. PubMed ID: 23337760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.
    Pandit-Taskar N; Batraki M; Divgi CR
    J Nucl Med; 2004 Aug; 45(8):1358-65. PubMed ID: 15299062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiopharmaceuticals for bone metastasis therapy and beyond: a voyage from the past to the present and a look to the future.
    Ferreira S; Dormehl I; Botelho MF
    Cancer Biother Radiopharm; 2012 Nov; 27(9):535-51. PubMed ID: 23075374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radionuclide therapy for bone metastases: new opportunities].
    Krylov VV; Kochetova TY; Voloznev LV
    Vopr Onkol; 2015; 61(1):14-9. PubMed ID: 26016139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radionuclide therapy and integrated protocols for bone metastases.
    Chiacchio S; Mazzarri S; Lorenzoni A; Nyakale N; Boni G; Borsò E; Alsharif A; Grosso M; Manca G; Greco C; Volterrani D; Mariani G
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):431-47. PubMed ID: 21738116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of [(90)Y]DOTA-conjugated bisphosphonate for treatment of painful bone metastases.
    Ogawa K; Kawashima H; Shiba K; Washiyama K; Yoshimoto M; Kiyono Y; Ueda M; Mori H; Saji H
    Nucl Med Biol; 2009 Feb; 36(2):129-35. PubMed ID: 19217524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates as radionuclide carriers for imaging or systemic therapy.
    Palma E; Correia JD; Campello MP; Santos I
    Mol Biosyst; 2011 Nov; 7(11):2950-66. PubMed ID: 21879109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabeled bone-seeking radiopharmaceuticals.
    Atkins HL; Srivastava SC
    Q J Nucl Med; 1996 Sep; 40(3):285-9. PubMed ID: 8961805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone pain palliation.
    DeNardo GL
    Cancer Biother Radiopharm; 1998 Dec; 13(6):407-11. PubMed ID: 10851433
    [No Abstract]   [Full Text] [Related]  

  • 17. [Multimodal imaging in bone metastases].
    Vaccaro A; Prisco MR; Gatta G
    Recenti Prog Med; 2012 Nov; 103(11):397-403. PubMed ID: 23096720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body iodine-131 metaiodobenzylguanidine imaging for detection of bone metastases in patients with paraganglioma: comparison with bone scintigraphy.
    Inoue T; Yoshinaga K; Morita K; Shiga T; Kanegae K; Hirata K; Okamoto S; Tamaki N
    Ann Nucl Med; 2007 Jul; 21(5):307-10. PubMed ID: 17634850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223.
    Anderson PM; Subbiah V; Rohren E
    Adv Exp Med Biol; 2014; 804():291-304. PubMed ID: 24924181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Choice of the imaging technique for the diagnosis of bone metastases].
    Genovese EA; Mallardo V; Rosati I; Prisco MR; Fontanarosa A; Della Vecchia N; D'Agosto G; Santagata M; Basile A
    Recenti Prog Med; 2013; 104(7-8):361-6. PubMed ID: 24042408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.